Glutamate and depression: clinical and preclinical studies.
about
Sigma receptors: potential targets for a new class of antidepressant drugThiamine nutritional status and depressive symptoms are inversely associated among older Chinese adultsThe neurobiological properties of tianeptine (Stablon): from monoamine hypothesis to glutamatergic modulationNeurochemistry of the nucleus accumbens and its relevance to depression and antidepressant action in rodentsInflammation Models of Depression in Rodents: Relevance to Psychotropic Drug DiscoveryReview of pharmacological treatment in mood disorders and future directions for drug development.Parallels between major depressive disorder and Alzheimer's disease: role of oxidative stress and genetic vulnerabilityNeuropharmacological profile of novel and selective 5-HT6 receptor agonists: WAY-181187 and WAY-208466Emerging targets for antidepressant therapiesCharacterization of an mGluR2/3 negative allosteric modulator in rodent models of depressionGlutamate receptor ion channels: structure, regulation, and functionNew approaches to antidepressant drug discovery: beyond monoaminesDeleterious GRM1 mutations in schizophreniaMetabotropic glutamate receptor 3 is associated with heroin dependence but not depression or schizophrenia in a Chinese populationNovel targets for antidepressant therapiesDoxepin and imipramine but not fluoxetine reduce the activity of the rat glutamate transporter EAAT3 expressed in Xenopus oocytesAmitriptyline inhibits the activity of the rat glutamate transporter EAAT3 expressed in Xenopus oocytes.Advances in the treatment of anxiety: targeting glutamate.Forebrain glutamatergic neurons mediate leptin action on depression-like behaviors and synaptic depressionWhich clinical and experimental data link temporal lobe epilepsy with depression?Dual constraints on synapse formation and regression in schizophrenia: neuregulin, neuroligin, dysbindin, DISC1, MuSK and agrin.Two populations of glutamatergic axons in the rat dorsal raphe nucleus defined by the vesicular glutamate transporters 1 and 2N-methyl-d-aspartic acid receptors are altered by stress and alcohol in Wistar-Kyoto rat brain.Psychotherapeutic benefits of opioid agonist therapy.Lithium acts as a potentiator of AMPAR currents in hippocampal CA1 cells by selectively increasing channel open probability.Modulation of induced frontocentral theta (Fm-θ) event-related (de-)synchronisation dynamics following mindfulness-based cognitive therapy in Major Depressive DisorderMagnetic resonance imaging of glutamate.Immunoexcitotoxicity as a central mechanism in chronic traumatic encephalopathy-A unifying hypothesis.Neuronal mechanisms underlying development of nicotine dependence: implications for novel smoking-cessation treatments.Glial and glutamatergic markers in depression, alcoholism, and their comorbidity.Utility of organotypic raphe slice cultures to investigate the effects of sustained exposure to selective 5-HT reuptake inhibitors on 5-HT release.Chronic treatment with zinc and antidepressants induces enhancement of presynaptic/extracellular zinc concentration in the rat prefrontal cortexAdvances in the treatment of depressionPremorbid risk factors for major depressive disorder: are they associated with early onset and recurrent course?Blockade of astrocytic glutamate uptake in rats induces signs of anhedonia and impaired spatial memory.Scopolamine produces larger antidepressant and antianxiety effects in women than in men.Neurocircuitry of mood disorders.Stress, depression, and neuroplasticity: a convergence of mechanisms.Novel drugs and therapeutic targets for severe mood disorders.In vivo ketamine-induced changes in [¹¹C]ABP688 binding to metabotropic glutamate receptor subtype 5.
P2860
Q24567770-B4A55600-C993-4282-B0F1-44A14580E172Q24600323-11A084DC-B7D8-412C-9EF7-910E93F6F1DEQ24613593-A5EA8F9E-7391-4EC7-A377-A0DB0B940B73Q24656267-911085AC-035C-4EB1-B04A-99D14E513A5BQ26749497-F3E27F6C-3379-4188-8ADE-C4453DBBBD8AQ26853509-B93D5805-50A3-49F9-BD17-B71D325C16D9Q27000066-636C5325-9E35-4A6D-97CE-B031320147F1Q28236198-AE19B04B-826F-4BC0-B131-C1F677059896Q28247614-80398161-D20A-40B0-9625-4C5F5E3090C6Q28253233-C5A80303-B1BE-4DE4-8C0A-0693465B8FCFQ28290774-90A20186-95AA-4434-ABB0-6D00B48E25BBQ28293089-D72CAFD9-CFAE-48ED-B419-9BA1B12A6114Q28481601-8A0DB861-7599-438F-9545-5C3965130F79Q28539376-14B588A0-F3F3-4759-BDED-6C4E7653DC00Q28648254-C8A2C473-0CDE-4FD2-A6DD-C6EFE562DD63Q30278879-0208B9AA-51DC-43B1-992F-80841141EB63Q30438911-63AA117A-D0D3-4C32-80DA-044D5B3E0856Q30457479-E66FAEB8-2847-4AD3-A903-21706C6BC48AQ30508512-69D9865E-1562-43F4-B2B2-F4CF8A163482Q31130656-EE200CA5-7256-4106-A452-8EEAFAC084FBQ31162413-557A5E3B-6B2A-4AA3-864C-2C46F9032E77Q33702477-2329B63D-4241-44E7-AC1E-817B86125623Q33976515-A2E406BC-B34E-4320-BA6B-DC5A02451898Q34014407-5C235604-CECC-4099-ADEE-97D0D598E68EQ34135203-0D51D00F-688C-47F2-8E83-3EB8DBB97650Q34135828-7B0503E1-583A-47F4-BD9D-266AB7E5A724Q34136735-8CEF31B6-AE1E-4471-B945-A3400140CDCDQ34213029-117869F8-FE92-4D4C-80E5-D683B1AAF58CQ34224871-4D6DEDA7-DB01-4078-8ADC-07E1A9F77F90Q34288391-B95A6045-0B10-4A71-A300-F575D8D09AECQ34442321-186A6590-9AE2-49E3-A954-A53848942E33Q34466775-369F2912-F280-4C4E-8B54-6D585EEDCF0DQ34496251-3F5D9C3B-E9A2-496F-8106-5B8A9A15F2BCQ34574186-AA1532E6-0EC7-4152-8EB0-6030E3282B63Q34660410-F325B39E-12C8-4941-B50F-B0CD4F5D6133Q34660507-81EC76AD-F3B0-4D44-8D98-B4A1DF1032EDQ34660904-C770382D-D484-41B9-9E52-E7AB80734812Q34686632-E777CD3C-1440-4B5F-92D6-3BD3CAA16495Q34732759-BDBCF2E6-6C07-4A18-ADE9-D575A9AE37BCQ34778858-CC2F08E9-2EEF-4E93-8EEF-2C0515B4CFEF
P2860
Glutamate and depression: clinical and preclinical studies.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Glutamate and depression: clinical and preclinical studies.
@ast
Glutamate and depression: clinical and preclinical studies.
@en
type
label
Glutamate and depression: clinical and preclinical studies.
@ast
Glutamate and depression: clinical and preclinical studies.
@en
prefLabel
Glutamate and depression: clinical and preclinical studies.
@ast
Glutamate and depression: clinical and preclinical studies.
@en
P356
P1476
Glutamate and depression: clinical and preclinical studies.
@en
P2093
Ian A Paul
Phil Skolnick
P304
P356
10.1196/ANNALS.1300.016
P407
P577
2003-11-01T00:00:00Z